Predicting type 1 diabetes

Current Diabetes Reports

Volumn 5, Issue 2, 2005, Pages 98-103

  Achenbach, Peter ^a   Bonifacio, Ezio ^a   Ziegler, Anette G ^a  

^a INSTITUT FÜR DIABETESFORSCHUNG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN ANTIBODY; PANCREAS ISLET CELL ANTIBODY;

ANTIBODY AFFINITY; ANTIBODY TITER; AUTOIMMUNITY; BAYES THEOREM; CELLULAR IMMUNITY; CHILDHOOD DISEASE; DISEASE COURSE; DISEASE PREDISPOSITION; FAMILY HISTORY; GENETIC HETEROGENEITY; GENETIC RISK; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENOTYPE; HIGH RISK POPULATION; HLA TYPING; HUMAN; HUMORAL IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET CELL FUNCTION; PREDICTION; REVIEW; RISK ASSESSMENT;

EID: 20444438794     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-005-0035-y     Document Type: Review

References (50)

1. Redondo MJ, Eisenbarth GS: Genetic control of autoimmunity in type I diabetes and associated disorders. Diabetologia 2002, 45:605-622.
2. Hermann R, Bartsocas CS, Soltesz G, et al.: Genetic screening for individuals at high risk for type 1 diabetes in the general population using HLA class II alleles as disease markers. A comparison between three European populations with variable rates of disease incidence. Diabetes Metab Res Rev 2004, 20:322-329.
3. Buzzetti R, Galgani A, Petrone A, et al.: Genetic prediction of type 1 diabetes in a population with low frequency of HLA risk genotypes and low incidence of the disease (the DIAB-FIN study). Diabetes Metab Res Rev 2004, 20:137-143.
4. Van der Auwera BJ, Schuit FC, Weets I, et al.: Relative and absolute HLA-DQA1-DQB1 linked risk for developing type I diabetes before 40 years of age in the Belgian population: implications for future prevention studies. Hum Immunol 2002, 63:40-50.
5. Lambert AP, Gillespie KM, Thomson G, et al.: Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom. J Clin Endocrinol Metab 2004, 89:4037-4043.
6. Gillespie KM, Gale EA, Bingley PJ: High familial risk and genetic susceptibility in early onset childhood diabetes. Diabetes 2002, 51:210-214.
7. Walter M, Albert E, Conrad M, et al.: IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of type 1 diabetes and associated autoimmunity. Diabetologia 2003, 46:712-720.
8. Nejentsev S, Sjoroos M, Soukka T, et al.: Population-based genetic screening for the estimation of type 1 diabetes mellitus risk in Finland: selective genotyping of markers in the HLA-DQB1, HLA-DQA1 and HLA-DRB1 loci. Diabet Med 1999, 16:985-992.
9. Rewers M, Bugawan TL, Norris JM, et al.: Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). Diabetologia 1996, 39:807-812.
10. Kupila A, Muona P, Simell T, et al.: Feasibility of genetic and immunological prediction of type I diabetes in a population-based birth cohort. Diabetologia 2001, 44:290-297.
11. Yu J, Yu L, Bugawan TL, et al.: Transient anti-islet autoantibodies: infrequent occurrence and lack of association with "genetic" risk factors. J Clin Endocrinol Metab 2000, 85:2421-2428.
12. Laine AP, Hermann R, Knip M, et al.: The human leukocyte antigen genotype has a modest effect on the insulin gene polymorphism-associated susceptibility to type 1 diabetes in the Finnish population. Tissue Antigens 2004, 63:72-74.
13. Motzo C, Contu D, Cordell HJ, et al.: Heterogeneity in the magnitude of the insulin gene effect on HLA risk in type 1 diabetes. Diabetes 2004, 53:3286-3291.
14. Ziegler AG, Schmid S, Huber D, et al.: Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. JAMA 2003, 290:1721-1728.
15. Norris JM, Barriga K, Klingensmith G, et al.: Timing of initial cereal exposure in infancy and risk of islet autoimmunity. JAMA 2003, 290:1713-1720.
16. Yu L, Cuthbertson DD, Eisenbarth GS, Krischer JP: Diabetes Prevention Trial 1: prevalence of GAD and ICA512 (IA-2) autoantibodies by relationship to proband. Ann N Y Acad Sci 2002, 958:254-258.
17. Bonifacio E, Hummel M, Walter M, et al.: IDDM1 and multiple family history of type 1 diabetes combine to identify neonates at high risk for type 1 diabetes. Diabetes Care 2004, 27:2695-2700.
18. Atkinson MA, Eisenbarth GS: Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 2001, 358:221-229.
19. Bingley PJ, Bonifacio E, Ziegler AG, et al.: Proposed guidelines on screening for risk of type 1 diabetes. Diabetes Care 2001, 24:398.
20. Bingley PJ, Bonifacio E, Mueller PW: Diabetes antibody standardization program: first assay proficiency evaluation. Diabetes 2003, 52:1128-1136.
21. Mire-Sluis AR, Gaines Das R, Lernmark A: The World Health Organization International Collaborative Study for islet cell antibodies. Diabetologia 2000, 43:1282-1292.
22. Kulmala P, Savola K, Petersen JS, et al.: Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group. J Clin Invest 1998, 101:327-336.
23. Decochez K, De Leeuw IH, Keymeulen B, et al.: IA-2 autoantibodies predict impending type I diabetes in siblings of patients. Diabetologia 2002, 45:1658-1666.
24. Bingley PJ, Williams AJ, Gale EA: Optimized autoantibody-based risk assessment in family members. Implications for future intervention trials. Diabetes Care 1999, 22:1796-1801.
25. Krischer JP, Cuthbertson DD, Yu L, et al.: Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes. J Clin Endocrinol Metab 2003, 88:103-108.
26. Achenbach P, Warncke K, Reiter J, et al.: Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics. Diabetes 2004, 53:384-392.
27. Achenbach P, Koczwara K, Knopff A, et al.: Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes. J Clin Invest 2004, 114:589-597.
28. Fourlanos S, Narendran F, Byrnes GB, et al.: Insulin resistance is a risk factor for progression to type 1 diabetes. Diabetologia 2004, 47:1661-1667.
29. Chase HP, Cooper S, Osberg I, et al.: Elevated C-reactive protein levels in the development of type 1 diabetes. Diabetes 2004, 53:2569-2573.
30. Yu L, Robles DT, Abiru N, et al.: Early expression of anti-insulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. Proc Natl Acad Sci U S A 2000, 97:1701-1706.
31. Ziegler AG, Hummel M, Schenker M, Bonifacio E: Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes 1999, 48:460-468.
32. Kimpimaki T, Kulmala P, Savola K, et al.: Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population. J Clin Endocrinol Metab 2002, 87:4572-4579.
33. Hummel M, Bonifacio E, Schmid S, et al.: Early appearance of islet autoantibodies predicts childhood type 1 diabetes in offspring of diabetic parents. Ann Intern Med 2004, 140:882-886.
34. Barker JM, Barriga KJ, Yu L, et al.: Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). J Clin Endocrinol Metab 2004, 89:3896-3902.
35. Colman PG, Steele C, Couper JJ, et al.: Islet autoimmunity in infants with a type I diabetic relative is common but is frequently restricted to one autoantibody. Diabetologia 2000, 43:203-209.
36. Naserke HE, Bonifacio E, Ziegler AG: Prevalence, characteristics and diabetes risk associated with transient maternally acquired islet antibodies and persistent islet antibodies in offspring of parents with type 1 diabetes. J Clin Endocrinol Metab 2001, 86:4826-4833.
37. Hamalainen AM, Ronkainen MS, Akerblom HK, Knip M: Postnatal elimination of transplacentally acquired disease-associated antibodies in infants born to families with type 1 diabetes. The Finnish TRIGR Study Group. Trial to Reduce IDDM in the Genetically at Risk. J Clin Endocrinol Metab 2000, 85:4249-4253.
38. Ziegler AG, Ziegler R, Vardi P, et al.: Life-table analysis of progression to diabetes of anti-insulin autoantibody-positive relatives of individuals with type I diabetes. Diabetes 1989, 38:1320-1325.
39. Bingley PJ, Christie MR, Bonifacio E, et al.: Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 1994, 43:1304-1310.
40. LaGasse JM, Brantley MS, Leech NJ, et al.: Successful prospective prediction of type 1 diabetes in schoolchildren through multiple defined autoantibodies: an 8-year follow-up of the Washington State Diabetes Prediction Study. Diabetes Care 2002, 25:505-511.
41. Strebelow M, Schlosser M, Ziegler B, et al.: Karlsburg type I diabetes risk study of a general population: frequencies and interactions of the four major type I diabetes-associated autoantibodies studied in 9419 schoolchildren. Diabetologia 1999, 42:661-670.
42. Bonifacio E, Bingley PJ, Shattock M, et al.: Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 1990, 335:147-149.
43. Vardi P, Ziegler AG, Mathews JH, et al.: Concentration of insulin autoantibodies at onset of type I diabetes. Inverse log-linear correlation with age. Diabetes Care 1988, 11:736-739.
44. Harrison LC, Honeyman MC, DeAizpurua HJ, et al.: Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 1993, 341:1365-1369.
45. Diabetes Prevention Trial - Type 1 Diabetes Study Group: Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med 2002, 346:1685-1691.
46. Chase HP, Cuthbertson DD, Dolan LM, et al.: First-phase insulin release during the intravenous glucose tolerance test as a risk factor for type 1 diabetes. J Pediatr 2001, 138:244-249.
47. Keskinen P, Korhonen S, Kupila A, et al.: First-phase insulin response in young healthy children at genetic and immunological risk for type I diabetes. Diabetologia 2002, 45:1639-1648.
48. Kulmala P, Savola V, Reijonen H, et al.: Genetic markers, humoral autoimmunity, and prediction of type 1 diabetes in siblings of affected children. Childhood Diabetes in Finland Study Group. Diabetes 2000, 49:48-58.
49. Pugliese A, Gianani R, Moromisato R, et al.: HLA-DQB1*0602 is associated with dominant protection from diabetes even among islet cell antibody-positive first-degree relatives of patients with IDDM. Diabetes 1995, 44:608-613.
50. Schlosser M, Wassmuth R, Strebelow M, et al.: Multiple and high-titer single autoantibodies in schoolchildren reflecting the genetic predisposition for type 1 diabetes. Ann N Y Acad Sci 2003, 1005:98-108.